Health
Experimental drug combination extends survival in mice with lung cancer, study finds – News-Medical.Net
A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival…

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.
Led by researchers at NYU Grossman School of Medicine and its Laura and Isaac Perlmutter Cancer…
Continue Reading